{"id":"W4379345563","doi":"10.1200/jco.2023.41.16_suppl.11563","title":"The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Synovial sarcoma; Internal medicine; Cohort; Oncology; Sarcoma; Interim analysis; Clinical endpoint; Fludarabine; Progression-free survival; Surgery; Gastroenterology; Cyclophosphamide; Chemotherapy; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001324323,0.0009747489,0.0009060019,0.0002960754,0.0002097733,0.0005343551,0.0005694089,0.0006988019,0.003716553],"category_scores_gemma":[0.0007630498,0.0002650018,0.001215112,0.0002645663,0.0004510891,0.0005029697,0.0003221154,0.001453516,0.0004717503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006816045,"about_ca_system_score_gemma":0.0009080436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008280618,"about_ca_topic_score_gemma":0.002565316,"domain_scores_codex":[0.9996077,0.0002333585,0.00001614022,0.00005776177,0.00003314307,0.00005198939],"domain_scores_gemma":[0.9995021,0.0001139831,0.0001250007,0.00003454891,0.00002240115,0.0002020665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9030737,0.007330202,0.009817833,0.000881278,0.00173584,0.0001698775,0.0001545019,0.001528368,0.01384021,0.0002825294,0.004085172,0.05710063],"study_design_scores_gemma":[0.6710359,0.2768624,0.03869084,0.0001250793,0.001899307,0.0005055137,0.00007158804,0.001946987,0.003876717,0.0004007735,0.004542201,0.00004268724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991815,0.003539693,0.0002821231,0.0002939236,0.00006465962,0.0008682762,0.00146975,0.00004109663,0.001625508],"genre_scores_gemma":[0.9875551,0.002234458,0.0009321407,0.0005055073,0.0001761172,0.001225806,0.004485362,0.00001582949,0.002869676],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003716553,"threshold_uncertainty_score":0.01243311,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1710643192867094,"score_gpt":0.5202117515068317,"score_spread":0.3491474322201223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}